Jeffrey A Davis's most recent trade in Laboratory Corp. Of America Holdings was a trade of 897 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 4,563 (0%) | 0% | - | Common Stock | |
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 25 Nov 2024 | 2,750 | 21,814 (0%) | 0% | 69.8 | 191,895 | Common Stock | |
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 01 Apr 2024 | 8,447 | 8,447 | - | - | Stock Option (right to buy) | ||
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 01 Apr 2024 | 5,518 | 22,764 (0%) | 0% | 0 | Common Stock | ||
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 31 Mar 2024 | 1,800 | 19,047 (0%) | 0% | 136.0 | 244,794 | Common Stock | |
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 31 Mar 2024 | 472 | 17,246 (0%) | 0% | 133.2 | 62,847 | Common Stock | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
Laboratory Corp. Of Americ... | Davis A. Jeffrey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 3,619 (0%) | 0% | - | Common Stock | |
Laboratory Corp. Of Americ... | A. Davis Jeffrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 25 Nov 2023 | 1,990 | 17,718 (0%) | 0% | 117.3 | 233,467 | Common Stock | |
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 31 Mar 2023 | 7,584 | 7,584 | - | - | Stock Option (right to buy) | ||
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 31 Mar 2023 | 4,702 | 19,708 (0%) | 0% | 0 | Common Stock | ||
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 27 Mar 2023 | 1,790 | 15,006 (0%) | 0% | 139.1 | 248,917 | Common Stock | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 2,672 (0%) | 0% | - | Common Stock | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 849 | 1,591 | - | - | Restricted Stock Unit | |
Dollar Tree Inc | Jeffrey A. Davis | Chief Financial Officer | 25 Nov 2022 | 13,216 | 13,216 (0%) | 0% | 151.3 | 1,999,977 | Common Stock | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 742 | 742 | - | - | Restricted Stock Unit | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 771 | 1,930 (0%) | 0% | - | Common Stock | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 771 | 0 | - | - | Restricted Stock Unit | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 986 | 1,159 (0%) | 0% | - | Common Stock | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 986 | 771 | - | - | Restricted Stock Unit | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2021 | 771 | 1,757 | - | - | Restricted Stock Unit | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 173 | 986 | - | - | Restricted Stock Unit | |
Laboratory Corp. Of Americ... | Jeffrey A. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 173 | 173 (0%) | 0% | - | Common Stock |